Nexgel (NXGLW) Change in Accured Expenses (2018 - 2025)
Nexgel's (NXGLW) quarterly Change in Accured Expenses came in at -$70000.0 in Q4 2025, up 76.82% YoY from -$39588.0 in Q4 2024, and down 1650.0% on a QoQ basis from -$4000.0 in Q3 2025.
Nexgel (NXGLW) Change in Accured Expenses (2018 - 2025) Analysis & Trends
Nexgel (NXGLW) has 8 years of Change in Accured Expenses data on file, last reported at -$70000.0 in Q4 2025.
- Quarterly Change in Accured Expenses rose 76.82% year-over-year to -$70000.0 in Q4 2025, while the trailing twelve-month figure through Dec 2025 was $150000.0 (up 134.56% YoY) and the FY2025 annual result came in at $150000.0, up 134.56% from the prior year.
- Change in Accured Expenses retreated to -$70000.0 in Q4 2025, from -$4000.0 in the prior quarter.
- In the past five years, Change in Accured Expenses ranged from a high of $200000.0 in Q2 2025 to a low of -$302000.0 in Q4 2024.
- A 5-year average of -$10300.0 and a median of -$3000.0 in 2022 frame the typical range for Change in Accured Expenses.
- Annual changes were most pronounced in 2022 — Change in Accured Expenses soared 1450.0% — and 2024, when it sank 1494.44%.
- Tracing NXGLW's Change in Accured Expenses over 5 years: stood at $3000.0 in 2021, then slumped by 1266.67% to -$35000.0 in 2022, then jumped by 354.29% to $89000.0 in 2023, then tumbled by 439.33% to -$302000.0 in 2024, then jumped by 76.82% to -$70000.0 in 2025.
- The last three Change in Accured Expenses figures came in at -$70000.0 (Q4 2025), -$4000.0 (Q3 2025), and $200000.0 (Q2 2025), per Business Quant data.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Change in Accured Expenses (Qtr) |
|---|---|---|---|---|---|
| 1 | Intuitive Surgical | 134.13 Bn | 128.91 Bn | 1.96 Bn | 55.00 Mn |
| 2 | Becton Dickinson | 52.76 Bn | 51.90 Bn | 2.32 Bn | - |
| 3 | Alcon | 35.81 Bn | 34.46 Bn | 1.68 Bn | - |
| 4 | Resmed | 33.72 Bn | 32.25 Bn | 861.22 Mn | 50.56 Mn |
| 5 | Medline | 29.38 Bn | 26.70 Bn | 2.22 Bn | 119.00 Mn |
| 6 | West Pharmaceutical Services | 25.00 Bn | 24.57 Bn | 329.20 Mn | - |
| 7 | Solventum | 15.46 Bn | 15.06 Bn | 1.29 Bn | 50.00 Mn |
| 8 | Cooper Companies | 14.88 Bn | 14.74 Bn | 735.40 Mn | - |
| 9 | Baxter International | 13.58 Bn | 11.43 Bn | 1.03 Bn | 29.00 Mn |
| 10 | Nexgel | 194,000.44 | -994,999.56 | 1.11 Mn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2025 | -70,000.00 |
| Dec 31, 2025 | -70,000.00 |
| Sep 30, 2025 | -4,000.00 |
| Sep 30, 2025 | -4,000.00 |
| Jun 30, 2025 | 200,000.00 |
| Jun 30, 2025 | 200,000.00 |
| Mar 31, 2025 | 24,000.00 |
| Mar 31, 2025 | 24,000.00 |
| Dec 31, 2024 | -302,000.00 |
| Dec 31, 2024 | -302,000.00 |
| Sep 30, 2024 | -19,000.00 |
| Sep 30, 2024 | -19,000.00 |
| Jun 30, 2024 | 174,000.00 |
| Jun 30, 2024 | 174,000.00 |
| Mar 31, 2024 | -287,000.00 |
| Mar 31, 2024 | -287,000.00 |
| Dec 31, 2023 | 89,000.00 |
| Dec 31, 2023 | 89,000.00 |
| Sep 30, 2023 | -139,000.00 |
| Sep 30, 2023 | -139,000.00 |